AU2005304107B2 - Method of preventive treatment of allergy by mucosal administration of an allergy vaccine - Google Patents

Method of preventive treatment of allergy by mucosal administration of an allergy vaccine Download PDF

Info

Publication number
AU2005304107B2
AU2005304107B2 AU2005304107A AU2005304107A AU2005304107B2 AU 2005304107 B2 AU2005304107 B2 AU 2005304107B2 AU 2005304107 A AU2005304107 A AU 2005304107A AU 2005304107 A AU2005304107 A AU 2005304107A AU 2005304107 B2 AU2005304107 B2 AU 2005304107B2
Authority
AU
Australia
Prior art keywords
allergen
subject
allergy
vaccine
clinical symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2005304107A
Other languages
English (en)
Other versions
AU2005304107A1 (en
Inventor
Jens Brimnes
Jens Kildsgaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALK Abello AS
Original Assignee
ALK Abello AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35840082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2005304107(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ALK Abello AS filed Critical ALK Abello AS
Publication of AU2005304107A1 publication Critical patent/AU2005304107A1/en
Application granted granted Critical
Publication of AU2005304107B2 publication Critical patent/AU2005304107B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2005304107A 2004-11-10 2005-11-08 Method of preventive treatment of allergy by mucosal administration of an allergy vaccine Ceased AU2005304107B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US62645404P 2004-11-10 2004-11-10
US60/626,454 2004-11-10
DKPA200401730 2004-11-10
DKPA200401730 2004-11-10
US68691405P 2005-06-03 2005-06-03
US60/686,914 2005-06-03
PCT/DK2005/000716 WO2006050729A2 (en) 2004-11-10 2005-11-08 Method of preventive treatment of allergy by mucosal administration of an allergy vaccine

Publications (2)

Publication Number Publication Date
AU2005304107A1 AU2005304107A1 (en) 2006-05-18
AU2005304107B2 true AU2005304107B2 (en) 2011-06-02

Family

ID=35840082

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005304107A Ceased AU2005304107B2 (en) 2004-11-10 2005-11-08 Method of preventive treatment of allergy by mucosal administration of an allergy vaccine

Country Status (10)

Country Link
US (1) US20060121064A1 (https=)
EP (1) EP1812059B1 (https=)
JP (1) JP5628473B2 (https=)
AT (1) ATE468135T1 (https=)
AU (1) AU2005304107B2 (https=)
CA (1) CA2586283A1 (https=)
DE (1) DE602005021388D1 (https=)
MX (1) MX2007005523A (https=)
PL (1) PL1812059T3 (https=)
WO (1) WO2006050729A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080070851A (ko) * 2005-11-04 2008-07-31 알크-아벨로 에이/에스 구강점막 투여용 액상 알레르기 백신 제형의 용도
EP2240202A2 (en) * 2008-01-08 2010-10-20 ALK-Abelló A/S Allergy vaccine composition for mucosal administration
DE202008006598U1 (de) * 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
WO2010009417A1 (en) * 2008-07-17 2010-01-21 John Shea Method for testing and treating delayed food allergies
US10080810B2 (en) 2008-07-17 2018-09-25 John Shea Method for testing and treating delayed food allergies
WO2011137422A2 (en) 2010-04-30 2011-11-03 Apellis Pharmaceuticals, Inc. Methods and articles for preventing or reducing risk of developing a hyperallergenic immune system
JP6062851B2 (ja) * 2010-04-30 2017-01-18 アロヴェイト・エルエルシー 口腔粘膜を介してアレルギーを減感作するための方法、物品及びキット
US20120100163A1 (en) * 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
KR20130118884A (ko) * 2010-10-15 2013-10-30 알크-아벨로 에이/에스 알레르겐 소스 물질로부터 유도된 무관련 알레르겐을 이용한 과민성 면역반응의 억제
FI20115374A0 (fi) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit
FI20115375A0 (fi) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
KR101858840B1 (ko) * 2016-01-15 2018-05-16 단국대학교 천안캠퍼스 산학협력단 집먼지진드기 유래 알레르겐에 의한 과민반응 면역조절제
FI128016B (en) 2018-01-04 2019-07-31 Desentum Oy Recombinant hypoallergenic Ecu c1 polypeptides for use in horse allergy immunotherapy
CN110531059A (zh) * 2019-09-27 2019-12-03 中国海洋大学 一种食物过敏原动态消化模型和体外模拟评价方法
US20240042017A1 (en) * 2021-02-02 2024-02-08 My-Or Diagnostics Ltd. Methods for preventing oral sensitization
CN115735854B (zh) * 2022-11-15 2025-02-11 中国农业大学 一种榛子食物过敏的动物模型构建方法
AU2024305143A1 (en) 2023-06-12 2026-01-08 Desentum Oy Hypoallergenic variants of major peanut allergen, ara h 2

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000045847A1 (en) * 1999-02-05 2000-08-10 Alk-Abelló A/S Novel mucosal delivery system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63159324A (ja) * 1986-12-22 1988-07-02 Lion Corp スギ花粉症用経口ワクチン
AUPM307793A0 (en) * 1993-12-22 1994-01-20 Holt, Patrick G Professor Prophylaxis of allergic disease
JPH09315998A (ja) * 1996-05-30 1997-12-09 Japan Tobacco Inc スギ花粉症の予防および／または治療剤
US20030175312A1 (en) * 2000-11-16 2003-09-18 Alk-Abello A/S Novel mutant allergens
CN1668737A (zh) * 2002-05-16 2005-09-14 阿尔克-阿贝洛有限公司 重组Bet.V.1过敏原突变体及其方法和制备
MXPA05005528A (es) * 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000045847A1 (en) * 1999-02-05 2000-08-10 Alk-Abelló A/S Novel mucosal delivery system

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CAFFARELL, C. ALLERGY, 2000. Vol.55: pages 1142-1147 *
FANTA, C. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1999 vol.120(3): pages 218-224 *

Also Published As

Publication number Publication date
EP1812059A2 (en) 2007-08-01
US20060121064A1 (en) 2006-06-08
PL1812059T3 (pl) 2010-10-29
AU2005304107A1 (en) 2006-05-18
HK1108568A1 (en) 2008-05-09
WO2006050729A2 (en) 2006-05-18
JP2008519776A (ja) 2008-06-12
JP5628473B2 (ja) 2014-11-19
MX2007005523A (es) 2007-07-05
ATE468135T1 (de) 2010-06-15
CA2586283A1 (en) 2006-05-18
EP1812059B1 (en) 2010-05-19
WO2006050729A3 (en) 2006-08-24
DE602005021388D1 (de) 2010-07-01

Similar Documents

Publication Publication Date Title
AU2005304107B2 (en) Method of preventive treatment of allergy by mucosal administration of an allergy vaccine
AU2006310881B2 (en) Use of a liquid allergy vaccine formulation for oromucosal administration
US20060171968A1 (en) Method of preventive treatment of allergy by oromucosal administration of an allergy vaccine
US20060002962A1 (en) Method of treating allergy and infection by eliciting an IGA antibody response
EP1793853B1 (en) Liquid allergy vaccine formulation for oromucosal administration
US20100086569A1 (en) Use of a first house dust mite group 2 allergen for treating allergy to a second house dust mite group 2 allergen
AU2005217696B2 (en) Method of evaluating the therapeutic potential of a vaccine for mucosal administration
ES2344915T3 (es) Procedimiento de tratamiento preventivo de alergia por administracion mucosal de una vacuna de alergia.
CN101098711A (zh) 通过口粘膜施用变态反应疫苗预防性治疗变态反应的方法
US20050202030A1 (en) Method of evaluating the therapeutic potential of a vaccine for mucosal administration
HK1108568B (en) Method of preventive treatment of allergy by mucosal administration of an allergy vaccine
HK1112188A (en) Method of preventive treatment of allergy by oromucosal administration of an allergy vaccine
HK1118009A (en) Method of preventive treatment of allergy by oromucosal administration of an allergy vaccine
MXPA06009737A (es) Metodo para evaluar el potencial terapeutico de una vacuna de administracion por la mucosa
HK1110773B (en) Use of a liquid allergy vaccine formulation for oromucosal administration

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired